Vascular Calcification Clinical Trial
Official title:
Modulation of Vascular Calcification in Chronic Dialysis Patients
50 patients will be randomized and treated with MCO or highflux dialysis for six months (24
weeks) after a run-in phase of 4 weeks Highflux treatment.
Serum samples will be drawn at baseline, after 4, 8 and 24 weeks.
Later, calcifiying vascular smooth muscle cells will be incubated with these serum samples
and calcification will be assessed with Alkaline phosphatase and Alizarin staining.
Primary endpoint:
In vitro Calcification of coronary vascular smooth muscle cells (Alkaline Phosphatase/ WST8)
after six months
Calcifiying vascular smooth muscle cells will be incubated with serum samples obtained after
six months of MCO/HF dialysis and calcification will be assessed with Alkaline phosphatase
and WST8.
Secondary Endpoints:
Aortic Pulse wave velocity after 6 months Calcification propensity after 6 months Physical
activity level after 6 months
Cell culture: Incubation of VSMC with serum samples obtained after 6 months
- Alizarin staining/WST-8
- Measurement of calcification inhibitors Osteopontin and Matrix Gla Protein in
Supernatants
- Apoptosis
The treatment regimen of the patients will not be altered, hence blood flow, dialysate flow
as well as dialysis time will remain constant.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03960437 -
The Effect of Etelcalcetide on CKD-MBD
|
Phase 2 | |
| Recruiting |
NCT04983875 -
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
|
N/A | |
| Completed |
NCT03292029 -
Pilot Medical Evaluation of the T50 Test
|
N/A | |
| Completed |
NCT02561299 -
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
|
N/A | |
| Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
| Active, not recruiting |
NCT02598635 -
Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
|
Phase 4 | |
| Completed |
NCT00183001 -
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
|
Phase 3 | |
| Completed |
NCT04114695 -
Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Not yet recruiting |
NCT03169400 -
Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)
|
N/A | |
| Completed |
NCT03314493 -
Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients
|
Phase 3 | |
| Completed |
NCT03839732 -
Observer Variability in Scoring Abdominal Aortic Calcifications and Vertebral Morphometry
|
||
| Completed |
NCT02610933 -
Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients
|
Phase 4 | |
| Completed |
NCT02542319 -
Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
|
Phase 2 | |
| Completed |
NCT00481364 -
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
|
Phase 3 | |
| Completed |
NCT00694824 -
Vascular Calcification's Risk Factors in Haemodialysis Patients
|
||
| Recruiting |
NCT01364688 -
Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
|
Phase 2 | |
| Completed |
NCT01675206 -
Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients
|
Phase 3 | |
| Completed |
NCT03937349 -
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
|
||
| Completed |
NCT02719665 -
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
|
N/A | |
| Recruiting |
NCT04753593 -
Use of Discarded Surgery Human Tissue Specimens for Basic Science Research
|